Paul Valbuena, MD
Psychiatry · Scottsdale, AZNPI 1902009145
Payments from drug & device makers
Across 196 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- AbbVie$961
- Takeda Pharmaceuticals U.S.A., Inc.$450
- Otsuka America Pharmaceutical, Inc.$200
- Sunovion Pharmaceuticals Inc.$142
- Neos Therapeutics, LP$136
- plus $884 from 17 others
What the payments were for
- Food & beverage$3,76099%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 32 | $1,018 |
| AbbVie(2 entities) | 51 | $961 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $450 |
| Otsuka America Pharmaceutical, Inc. | 9 | $200 |
| Sunovion Pharmaceuticals Inc. | 12 | $142 |
| Neos Therapeutics, LP | 18 | $136 |
| Lundbeck LLC | 6 | $128 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $114 |
| Alkermes, Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Ironshore Pharmaceuticals Inc. | 3 | $70 |
| Orexo US, Inc. | 3 | $57 |
| Corium, LLC | 5 | $57 |
| Supernus Pharmaceuticals, Inc. | 4 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Arbor Pharmaceuticals, Inc. | 3 | $40 |
| Indivior Inc. | 2 | $30 |
| OWP Pharmaceuticals, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,790 in reported general payments places this provider in the 85th percentile of 573 psychiatry providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 57 | $1,575 |
| Quetiapine Fumarate | 25 | $1,110 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $526 |
| Hydroxyzine Pamoate | 24 | $348 |
| Clonazepam | 35 | $319 |
| Trazodone Hcl | 34 | $318 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $259 |
| Fluoxetine Hcl | 31 | $251 |
| Zolpidem Tartrate | 31 | $249 |
| Lorazepam | 34 | $230 |
| Aripiprazole | 17 | $192 |
| Citalopram HbrCitalopram Hydrobromide | 27 | $122 |
| Sertraline Hcl | 36 | $119 |
| Alprazolam | 26 | $75 |
| Lamotrigine | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Scottsdale
- Lois KrahnScottsdale$195K
- Henry SchulteScottsdale$77K
- Lauren BonnerScottsdale$44K
- Alvin BursteinScottsdale$18K
- Marie GronleyScottsdale$8K
- Alpa SanghviScottsdale$6K
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Katherine KelleyChandler$610K
- Payam SadrMesa$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.